Le Lézard
Classified in: Health, Covid-19 virus
Subjects: ANW, MRR

Global Animal Drug Compounding Market Set to Reach $2.07 Billion by 2027 with a CAGR of 7.3%


DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The "Animal Drug Compounding Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global animal drug compounding market is experiencing significant growth, with projections indicating an increase from $1.44 billion in 2022 to $1.56 billion in 2023, reflecting a Compound Annual Growth Rate (CAGR) of 8.4%. The market is expected to reach $2.07 billion by 2027, with a CAGR of 7.3%.

Leading Players in the Animal Drug Compounding Market

Prominent players in the animal drug compounding market include:

Reasons to Consider This Market

  1. Gain a comprehensive global perspective on the animal drug compounding market, covering over 50 geographies.
  2. Understand the market's response to the impact of COVID-19 as the effects of the virus subside.
  3. Assess the implications of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and its direct and indirect impact on the market.
  4. Measure how high global inflation is affecting market growth.
  5. Develop regional and country-specific strategies based on local data and analysis.
  6. Identify growth segments for potential investments.
  7. Outperform competitors with forecast data and insights into the drivers and trends shaping the market.
  8. Understand customer preferences based on the latest market shares.
  9. Benchmark your performance against key competitors.
  10. Support your internal and external presentations with reliable, high-quality data and analysis.

About Animal Drug Compounding

Animal drug compounding involves mixing and altering the ingredients of multiple medicines to create customized treatments for individual animals or groups of animals. It plays a crucial role in veterinary medicine by addressing the specific needs of various animals, including companion and livestock animals. These customized medications are administered through various routes, such as oral, injectable, and topical, and find applications in veterinary hospitals, clinics, and diagnostic centers.

Market Segmentation

Key product categories in the animal drug compounding market include anti-infective agents, anti-inflammatory agents, hormones and substitutes, CNS agents, and other products. These agents are essential for treating and preventing various animal health conditions, ranging from infections to hormonal imbalances.

Global Reach

The animal drug compounding market spans across multiple regions, including North America, Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa. Leading countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

Adoption of Customized Medications

The rise in animal adoption is expected to drive the growth of the animal drug compounding market. As more pet owners adopt animals with pre-existing health conditions or unique needs, there is an increasing demand for customized medications that may not be available in standard formulations. This trend underscores the importance of animal drug compounding in addressing the individual health requirements of animals.

About the Report

The animal drug compounding market research report offers comprehensive insights, market statistics, and in-depth analysis of current and future industry scenarios. It provides data on market size, regional shares, competitive players, market segments, trends, opportunities, and other essential information necessary to thrive in the animal drug compounding industry.

Key Topics Covered:

1. Executive Summary

2. Animal Drug Compounding Market Characteristics

3. Animal Drug Compounding Market Trends And Strategies

4. Animal Drug Compounding Market - Macro Economic Scenario
4.1. COVID-19 Impact On Animal Drug Compounding Market
4.2. Ukraine-Russia War Impact On Animal Drug Compounding Market
4.3. Impact Of High Inflation On Animal Drug Compounding Market

5. Animal Drug Compounding Market Size And Growth
5.1. Global Animal Drug Compounding Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Animal Drug Compounding Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Animal Drug Compounding Market Segmentation
6.1. Global Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

6.2. Global Animal Drug Compounding Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

6.3. Global Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

6.4. Global Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

7. Animal Drug Compounding Market Regional And Country Analysis
7.1. Global Animal Drug Compounding Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Animal Drug Compounding Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/m756oi

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:00
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...



News published on and distributed by: